Compugen Ltd.
CGEN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 50.4% | -45% | 55.3% | – |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | 12.7% | -32.5% | -5.1% | 54.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -366.9% | -585.4% | -367.6% | -508.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -369.1% | -584.1% | -314.4% | -415.8% |
| EPS Diluted | -0.075 | -0.079 | -0.078 | -0.068 |
| % Growth | 5% | -0.9% | -13.9% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |